BRIEF-Amgen and UCB submit biologics license application for romosozumab to the FDA By: Reuters: Company News July 22, 2016 at 01:05 AM EDT * Amgen and UCB submit biologics license application for romosozumab to the FDA Read More >> Related Stocks: Amgen